Kythera Biopharmaceuticals Inc news

   Watch this stock
Showing stories 1 - 10 of about 16   

Articles published

KYTH 32.64 -0.12 (-0.37%)
price chart
Commit To Purchase Kythera Biopharmaceuticals At $30, Earn 12.1 ...
Investors considering a purchase of Kythera Biopharmaceuticals, Inc. (Symbol: KYTH) shares, but cautious about paying the going market price of $37.18/share, might benefit from considering selling puts among the alternative strategies at their disposal.
KYTHERA Biopharmaceuticals Director Nathaniel E. David Sells 1540 Shares ...
Analysts expect that KYTHERA Biopharmaceuticals will post $-3.34 EPS for the current fiscal year. KYTHERA Biopharmaceuticals, Inc is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of ...
Insider Selling: KYTHERA Biopharmaceuticals Director Sells 1540 Shares of ...
KYTHERA Biopharmaceuticals logo KYTHERA Biopharmaceuticals (NASDAQ:KYTH) Director Nathaniel E. David sold 1,540 shares of the stock in a transaction that occurred on Tuesday, September 2nd.
Active Stocks to Watch: Vodafone Group Plc (ADR) (NASDAQ:VOD), CBD ...
Kythera Biopharmaceuticals, Inc. (NASDAQ:KYTH) has 2.20% insider ownership while its institutional ownership stands at 33.20%.
A Newer Nifty Fifty State Index: Replacements Rule!
Kythera Biopharmaceuticals, Inc. (NASDAQ:KYTH) was projected to net $453.86 based on 1yr. target price estimates from five analysts plus dividends less $20 broker fees.
Eye Catching Stocks: Vale S.A. (NYSE:VALE), FireEye (NASDAQ:FEYE), China ...
On last trading day Kythera Biopharmaceuticals, Inc. (NASDAQ:KYTH) moved down -1.24% to close at $35.76. KYTH is -36.55% away from its 52 week high and is moving 21.22% ahead of its 52 week low.
Investors Alert: Coupons.com Incorporated (NYSE:COUP), Ohr Pharmaceutical ...
KYTHERA Biopharmaceuticals Inc. (NASDAQ:KYTH) CEO Keith R. Leonard sold 1,828 shares of the stock in a transaction that occurred on Monday, August 4th.